As part of a new Asia-Pacific (APAC) Life Sciences and Health Care webinar program designed both for companies with commercial interests in APAC and for companies based in the region, Hogan Lovells is hosting a special...more
China’s Supreme People’s Court (SPC) recently circulated its Draft “Provisions on Several Issues concerning the Adjudication of Administrative Cases on Granting and Affirming Patent Rights (I)”...more
8/17/2018
/ Administrative Review ,
China ,
Claim Construction ,
Design Patent ,
Life Sciences ,
Patent Examinations ,
Patent Validity ,
Patents ,
Regulatory Oversight ,
Regulatory Standards ,
Supreme People's Court of China
On 12 May 2017, the Chinese Food and Drug Administration (the “CFDA”) issued several draft policies aimed at overhauling of the current regulations governing the Chinese pharma and medical device sector (the “Draft...more